カテゴリー： Stratistics MRC, 世界, 医療/バイオ

神経血管デバイスの世界市場予測（～2027年）

◆英語タイトル：Neurovascular Devices Market Forecasts to 2028 – Global Analysis By Product (Cerebral Balloon Angioplasty, Aneurysm Coiling, Neurothrombectomy Devices, Support Devices, Stenting Systems, Embolization Devices and Other Products), Application (Ischemic Stroke, Cerebral Aneuryms, Carotid Artery Stenosis and Arteriovenous Malformations & Fistulas), End User (Hospitals, Speciality Clinics, Ambulatory Care Centers and Other End Users), and By Geography

Stratistics MRCが発行した調査報告書（SMR23MR034）◆商品コード：SMR23MR034
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2023年2月
◆ページ数：約150
◆レポート形式：英語 / Eメール
◆納品方法：英語
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Global Site LicenseUSD4,150 ⇒換算￥630,800見積依頼/購入/質問フォーム
PDFUSD7,500 ⇒換算￥1,140,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）

❖ レポートの概要 ❖

ストラティスティックスMRC社は、世界の神経血管デバイス市場規模が2022年27.6億ドルから2028年50.6億ドルになり、予測期間中に年平均10.6%で成長すると予測しています。本報告書では、神経血管デバイスの世界市場を調査し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品別（脳バルーン血管形成術、動脈瘤コイリング、神経血栓切除術デバイス、サポートデバイス、ステントシステム、塞栓術デバイス、その他）分析、用途別（虚血性脳卒中、脳動脈瘤、頸動脈狭窄、動静脈奇形&フィスチュラ）分析、エンドユーザー別（病院、専門クリニック、外来診療センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ）分析、最近の動向、企業情報など、次のように掲載しています。また、企業情報としては、Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc, Terumo Corporation, MicroPort Scientific Corporation, Shape Memory Medical, Imperative Care, Integer Holdings Corporationなどが含まれています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の神経血管デバイス市場規模：製品別
- 脳バルーン血管形成術の市場規模
- 動脈瘤コイリングの市場規模
- 神経血栓切除術デバイスの市場規模
- サポートデバイスの市場規模
- その他製品の市場規模
・世界の神経血管デバイス市場規模：用途別
- 虚血性脳卒中における市場規模
- 脳動脈瘤における市場規模
- 頸動脈狭窄における市場規模
- 動静脈奇形&フィスチュラにおける市場規模
・世界の神経血管デバイス市場規模：エンドユーザー別
- 病院における市場規模
- 専門クリニックにおける市場規模
- 外来診療センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の神経血管デバイス市場規模：地域別
- 北米の神経血管デバイス市場規模
- ヨーロッパの神経血管デバイス市場規模
- アジア太平洋の神経血管デバイス市場規模
- 南米の神経血管デバイス市場規模
- 中東・アフリカの神経血管デバイス市場規模
・最近の動向
・企業情報

According to Stratistics MRC, the Global Neurovascular Devices Market is accounted for $2.76 billion in 2022 and is expected to reach $5.06 billion by 2028 growing at a CAGR of 10.6% during the forecast period. Neurovascular problems are treated with neurovascular devices. The neurovascular illnesses might cause the patient to experience significant disability or perhaps pass away because they are brought on by inadequate or constrained blood and oxygen supply to the brain. Strokes, brain aneurysms, arteriovenous malformations, and stenosis can result from this. The global prevalence of neurovascular illnesses is driving acceleration in the market for neurovascular devices. In order to diagnose and treat disorders of the brain and central nervous system, neurological gadgets are routinely utilised. Because of advances in technology in neurology, there is a growing demand for neurovascular devices.

According to the Brain Aneurysm Foundation, 6 million Americans are thought to experience brain aneurysms annually. Additionally, every year, the illness kills half a million people worldwide. These trends are creating a sizable patient population that needs medical attention.

Key players in the market

Some of the key players profiled in the Neurovascular Devices Market include Johnson & Johnson Services, Inc., Medtronic, Penumbra, Inc, Terumo Corporation, MicroPort Scientific Corporation, Shape Memory Medical, Imperative Care, Integer Holdings Corporation, ASAHI INTECC CO., LTD, Stryker, Microvention Inc, Codman Neuro, Merit Medical Systems, W.L.Gore & Associates, Inc and Acandis GmbH.

Key Developments:

In Dec 2022, Johnson & Johnson the world’s largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.

In Dec 2022, The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab) in combination with lenalidomide and dexamethasone (D-Rd), evaluating progression-free survival (PFS), minimal residual disease (MRD) negativity and overall response rate (ORR) at a median follow up.

In Dec 2022, the Johnson & Johnson announced updated results from the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody. Talquetamab targets both GPRC5D, a novel target on multiple myeloma cells, and CD3 on T cells, activating the body’s immune system to fight this blood cancer.

In Dec 2022, Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system the Hugo™ RAS system is intended to be used in this study for urologic surgical procedures including radical prostatectomy, radical cystectomy, and nephrectomy (partial or radical) procedures at sites in the U.S.

Products Covered:
• Cerebral Balloon Angioplasty
• Aneurysm Coiling
• Neurothrombectomy Devices
• Support Devices
• Stenting Systems
• Embolization Devices
• Other Products

Applications Covered:
• Ischemic Stroke
• Cerebral Aneuryms
• Carotid Artery Stenosis
• Arteriovenous Malformations & Fistulas

End Users Covered:
• Hospitals
• Speciality Clinics
• Ambulatory Care Centers
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurovascular Devices Market, By Product
5.1 Introduction
5.2 Cerebral Balloon Angioplasty
5.3 Aneurysm Coiling
5.4 Neurothrombectomy Devices
5.5 Support Devices
5.6 Stenting Systems
5.7 Embolization Devices
5.8 Other Products
6 Global Neurovascular Devices Market, By Application
6.1 Introduction
6.2 Ischemic Stroke
6.3 Cerebral Aneuryms
6.4 Carotid Artery Stenosis
6.5 Arteriovenous Malformations & Fistulas
7 Global Neurovascular Devices Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Speciality Clinics
7.4 Ambulatory Care Centers
7.5 Other End Users
8 Global Neurovascular Devices Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Johnson & Johnson Services, Inc.
10.2 Medtronic
10.3 Penumbra, Inc.
10.4 Terumo Corporation
10.5 MicroPort Scientific Corporation
10.6 Shape Memory Medical
10.7 Imperative Care
10.8 Integer Holdings Corporation
10.9 ASAHI INTECC CO., LTD.
10.10 Stryker
10.11 Microvention Inc
10.12 Codman Neuro
10.13 Merit Medical Systems
10.14 W.L.Gore & Associates, Inc
10.15 Acandis GmbH
List of Tables
Table 1 Global Neurovascular Devices Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 3 Global Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 4 Global Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 5 Global Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 6 Global Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 7 Global Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 8 Global Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 9 Global Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 10 Global Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 11 Global Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 12 Global Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 13 Global Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 14 Global Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 15 Global Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 16 Global Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 17 Global Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 18 Global Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 19 Global Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
Table 20 North America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
Table 21 North America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 22 North America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 23 North America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 24 North America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 25 North America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 26 North America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 27 North America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 28 North America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 29 North America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 30 North America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 31 North America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 32 North America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 33 North America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 34 North America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 35 North America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 36 North America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 37 North America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 38 North America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
Table 39 Europe Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
Table 40 Europe Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 41 Europe Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 42 Europe Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 43 Europe Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 44 Europe Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 45 Europe Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 46 Europe Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 47 Europe Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 48 Europe Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 49 Europe Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 50 Europe Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 51 Europe Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 52 Europe Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 53 Europe Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 54 Europe Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 55 Europe Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 56 Europe Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 57 Europe Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
Table 58 Asia Pacific Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
Table 59 Asia Pacific Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 60 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 61 Asia Pacific Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 62 Asia Pacific Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 63 Asia Pacific Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 64 Asia Pacific Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 65 Asia Pacific Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 66 Asia Pacific Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 67 Asia Pacific Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 68 Asia Pacific Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 69 Asia Pacific Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 70 Asia Pacific Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 71 Asia Pacific Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 72 Asia Pacific Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 73 Asia Pacific Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 74 Asia Pacific Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 75 Asia Pacific Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 76 Asia Pacific Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
Table 77 South America Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
Table 78 South America Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 79 South America Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 80 South America Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 81 South America Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 82 South America Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 83 South America Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 84 South America Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 85 South America Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 86 South America Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 87 South America Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 88 South America Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 89 South America Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 90 South America Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 91 South America Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 92 South America Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 93 South America Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 94 South America Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 95 South America Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)
Table 96 Middle East & Africa Neurovascular Devices Market Outlook, By Country (2020-2028) ($MN)
Table 97 Middle East & Africa Neurovascular Devices Market Outlook, By Product (2020-2028) ($MN)
Table 98 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Balloon Angioplasty (2020-2028) ($MN)
Table 99 Middle East & Africa Neurovascular Devices Market Outlook, By Aneurysm Coiling (2020-2028) ($MN)
Table 100 Middle East & Africa Neurovascular Devices Market Outlook, By Neurothrombectomy Devices (2020-2028) ($MN)
Table 101 Middle East & Africa Neurovascular Devices Market Outlook, By Support Devices (2020-2028) ($MN)
Table 102 Middle East & Africa Neurovascular Devices Market Outlook, By Stenting Systems (2020-2028) ($MN)
Table 103 Middle East & Africa Neurovascular Devices Market Outlook, By Embolization Devices (2020-2028) ($MN)
Table 104 Middle East & Africa Neurovascular Devices Market Outlook, By Other Products (2020-2028) ($MN)
Table 105 Middle East & Africa Neurovascular Devices Market Outlook, By Application (2020-2028) ($MN)
Table 106 Middle East & Africa Neurovascular Devices Market Outlook, By Ischemic Stroke (2020-2028) ($MN)
Table 107 Middle East & Africa Neurovascular Devices Market Outlook, By Cerebral Aneuryms (2020-2028) ($MN)
Table 108 Middle East & Africa Neurovascular Devices Market Outlook, By Carotid Artery Stenosis (2020-2028) ($MN)
Table 109 Middle East & Africa Neurovascular Devices Market Outlook, By Arteriovenous Malformations & Fistulas (2020-2028) ($MN)
Table 110 Middle East & Africa Neurovascular Devices Market Outlook, By End User (2020-2028) ($MN)
Table 111 Middle East & Africa Neurovascular Devices Market Outlook, By Hospitals (2020-2028) ($MN)
Table 112 Middle East & Africa Neurovascular Devices Market Outlook, By Speciality Clinics (2020-2028) ($MN)
Table 113 Middle East & Africa Neurovascular Devices Market Outlook, By Ambulatory Care Centers (2020-2028) ($MN)
Table 114 Middle East & Africa Neurovascular Devices Market Outlook, By Other End Users (2020-2028) ($MN)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 神経血管デバイスの世界市場予測（～2027年）(Neurovascular Devices Market Forecasts to 2028 – Global Analysis By Product (Cerebral Balloon Angioplasty, Aneurysm Coiling, Neurothrombectomy Devices, Support Devices, Stenting Systems, Embolization Devices and Other Products), Application (Ischemic Stroke, Cerebral Aneuryms, Carotid Artery Stenosis and Arteriovenous Malformations & Fistulas), End User (Hospitals, Speciality Clinics, Ambulatory Care Centers and Other End Users), and By Geography)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 神経血管デバイスのグローバル市場（～2027）：脳バルーン血管形成術、動脈瘤コイリング、神経血栓切除術デバイス、サポートデバイス、ステントシステム、塞栓術デバイス、その他
  • 神経血管デバイスの世界市場予測（～2028）：病態別、エンドユーザー別、地域別
  • 耳鼻咽喉科用レーザーデバイスの世界市場予測（～2027年）

    • ◆H&Iグローバルリサーチのお客様（例）◆